Cross-modal and cross-language activation in bilinguals reveals lexical competition even when words or signs are unheard or unseen.

We exploit the phenomenon of cross-modal, cross-language activation to examine the dynamics of language processing. Previous within-language work showed that seeing a sign coactivates phonologically related signs, just as hearing a spoken word coactivates phonologically related words. In this study, we conducted a series of eye-tracking experiments using the visual world paradigm to investigate the time course of cross-language coactivation in hearing bimodal bilinguals (Spanish-Spanish Sign Language) and unimodal bilinguals (Spanish/Basque). The aim was to gauge whether (and how) seeing a sign could coactivate words and, conversely, how hearing a word could coactivate signs and how such cross-language coactivation patterns differ from within-language coactivation. The results revealed cross-language, cross-modal activation in both directions. Furthermore, comparison with previous findings of within-language lexical coactivation for spoken and signed language showed how the impact of temporal structure changes in different modalities. Spoken word activation follows the temporal structure of that word only when the word itself is heard; for signs, the temporal structure of the sign does not govern the time course of lexical access (location coactivation precedes handshape coactivation)-even when the sign is seen. We provide evidence that, instead, this pattern of activation is motivated by how common in the lexicon the sublexical units of the signs are. These results reveal the interaction between the perceptual properties of the explicit signal and structural linguistic properties. Examining languages across modalities illustrates how this interaction impacts language processing.

Reading without phonology: ERP evidence from skilled deaf readers of Spanish.

Reading typically involves phonological mediation, especially for transparent orthographies with a regular letter to sound correspondence. In this study we ask whether phonological coding is a necessary part of the reading process by examining prelingually deaf individuals who are skilled readers of Spanish. We conducted two EEG experiments exploiting the pseudohomophone effect, in which nonwords that sound like words elicit phonological encoding during reading. The first, a semantic categorization task with masked priming, resulted in modulation of the N250 by pseudohomophone primes in hearing but not in deaf readers. The second, a lexical decision task, confirmed the pattern: hearing readers had increased errors and an attenuated N400 response for pseudohomophones compared to control pseudowords, whereas deaf readers did not treat pseudohomophones any differently from pseudowords, either behaviourally or in the ERP response. These results offer converging evidence that skilled deaf readers do not rely on phonological coding during visual word recognition. Furthermore, the finding demonstrates that reading can take place in the absence of phonological activation, and we speculate about the alternative mechanisms that allow these deaf individuals to read competently.

Language modality shapes the dynamics of word and sign recognition.

Spoken words and signs both consist of structured sub-lexical units. While phonemes unfold in time in the case of the spoken signal, visual sub-lexical units such as location and handshape are produced simultaneously in signs. In the current study we investigate the role of sub-lexical units in lexical access in spoken Spanish and in Spanish Sign Language (LSE) in hearing early bimodal bilinguals and in hearing second language (L2) learners of LSE, both native speakers of Spanish, using the visual world paradigm. Experiment 1 investigated phonological competition in spoken Spanish from words sharing onset or rhyme. Experiment 2 investigated competition in LSE from signs sharing handshape or location. For Spanish, the results confirm previous findings for word recognition: onset competition comes first and is more salient than rhyme competition. For sign recognition, native bimodal bilinguals (native speakers of spoken and signed languages) showed earlier competition from location than handshape, and overall stronger competition from handshape compared to location. Hearing bimodal bilinguals who learned LSE as a second language also experienced competition from both signed parameters. However, they showed later effects for location competitors and weaker effects for handshape competitors than native signers. Our results demonstrate that the temporal dynamics of spoken words and signs impact the time course of lexical co-activation. Furthermore, age of acquisition of the signed language modulates sub-lexical processing of signs, and may reflect enhanced abilities of native signers to use early phonological cues in transition movements to constrain sign recognition.

Language switching across modalities: Evidence from bimodal bilinguals.

This study investigated whether language control during language production in bilinguals generalizes across modalities, and to what extent the language control system is shaped by competition for the same articulators. Using a cued language-switching paradigm, we investigated whether switch costs are observed when hearing signers switch between a spoken and a signed language. The results showed an asymmetrical switch cost for bimodal bilinguals on reaction time (RT) and accuracy, with larger costs for the (dominant) spoken language. Our findings suggest important similarities in the mechanisms underlying language selection in bimodal bilinguals and unimodal bilinguals, with competition occurring at multiple levels other than phonology. (PsycINFO Database Record

Why space is not one-dimensional: Location may be categorical and imagistic.

In our commentary, we raise concerns with the idea that location should be considered a gestural component of sign languages. We argue that psycholinguistic studies provide evidence for location as a "categorical" element of signs. More generally, we propose that the use of space in sign languages comes in many flavours and may be both categorical and imagistic. In their target article, Goldin-Meadow & Brentari (G-M&B) discuss several observations suggesting that the use of space is imagistic and may not form part of the categorical properties of sign languages. Specifically, they point out that (1) the number of locations toward which agreeing verbs can be directed is not part of a discrete set, (2) event descriptions by users of different sign languages and hearing nonsigners exhibit marked similarities in the use of space, and (3) location as a phonological parameter is not categorically perceived by native signers. It should be noted that G-M&B acknowledge that categorical properties of location and movement may simply not have been captured yet because the proper investigative tools are not yet readily available.

LSE-Sign: A lexical database for Spanish Sign Language.

The LSE-Sign database is a free online tool for selecting Spanish Sign Language stimulus materials to be used in experiments. It contains 2,400 individual signs taken from a recent standardized LSE dictionary, and a further 2,700 related nonsigns. Each entry is coded for a wide range of grammatical, phonological, and articulatory information, including handshape, location, movement, and non-manual elements. The database is accessible via a graphically based search facility which is highly flexible both in terms of the search options available and the way the results are displayed. LSE-Sign is available at the following website: http://www.bcbl.eu/databases/lse/.

Perfusion of 99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target.

There is strong published and unpublished evidence that our CD105 Mab E9, which is highly reactive with angiogenic endothelial cells, could be a useful reagent to target the vasculature of solid tumors in man. Since Mab E9 does not cross-react with animal tissues, we undertook here to evaluate its localization using human kidney as an ex vivo model. Perfusion was performed through the renal artery of 99Tcm-labeled purified CD105 Mab in freshly excised kidneys from 7 patients with renal carcinoma. In all 7 cases, immunoscintigraphs showed the presence of well-defined radioactive hot spots, which matched the positions of the tumors as identified by presurgery MRI scans and subsequent histopathologic examination. Importantly, in one instance, where a presurgery MRI scan had identified only one tumor, immunoscintigraphs showed 2 distinct hot spots of radioactivity. The pathology report confirmed that the additional hot spot corresponded to a small secondary well-vascularized tumor. The implication of this finding is that the radiolabeled Mab, E9, may be of use in the detection of metastatic disease. That the labeling of tumors was specific was confirmed when prior perfusion of unlabeled mab E9 in 2 kidneys completely blocked the localization of 99Tcm-conjugated Mab E9. Radioactivity in samples of tumor and normal tissue taken from 7 kidneys was counted in a gamma counter. In all cases, there was a greater uptake of radioactivity in tumors compared with the corresponding normal kidneys. The median values, adjusted per gram wet weight, for 99Tcm were 14.8 times (range, 4.8-113.0) greater in kidney tumors than in normal kidney tissue (p < 0.007). Immunofluorescent staining of cryostat sections of tumor tissues in each of the 7 cases showed strong and uniform localization of Mab E9 in tumor microvessels. Interestingly, chimeric staining of endothelial cells (ECs) was seen in an occasional microvessel segment. That is, while most of the ECs lining a microvessel were strongly stained, an occasional EC was negative. This was not an artifact of staining. Unstained ECs may be nonangiogenic or apoptotic since CD105 is a proliferation/activation-associated antigen. Further investigations are warranted to establish the pharmacokinetics of 99Tcm-labeled CD105 antibody in vivo. This would enable us to determine whether an apparently highly successful ex vivo study has the potential for tumor imaging/therapeutic vascular targeting in patients with cancer.